Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**MedActive Oral Relief** is a branded over-the-counter oral-demulcent product line from Integrate Oral Care for temporary relief of minor oral and throat discomfort and protection of irritated oral tissue. Formulations include lozenges, oral spray, and gel; the labelled active ingredient differs by formulation, including pectin 2.8 mg per lozenge or glycerin 6% in the spray. The products use the proprietary ULTRAMULSION coating system, incorporating dimethicone and poloxamer, with Spilanthes extract. Its therapeutic effect is primarily local and physical: it coats, lubricates, moistens, and soothes oral soft tissue; Spilanthes extract is marketed as supporting salivary flow. The product line is used for oral discomfort associated with dry mouth and related conditions, although the formal OTC labels specify temporary relief of minor discomfort and protection of irritated areas in sore mouth and sore throat.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MedActive Oral Relief.